{"name": "Isogenica",
 "permalink": "isogenica",
 "crunchbase_url": "http://www.crunchbase.com/company/isogenica",
 "homepage_url": "http://www.isogenica.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "44 12 2349 6720",
 "description": "",
 "created_at": "Mon Sep 21 14:45:21 UTC 2009",
 "updated_at": "Sat Dec 01 11:25:09 UTC 2012",
 "overview": "\u003Cp\u003EIsogenica Limited, a biotechnology company, develops therapeutic peptides to treat diseases. The company\u00e2\u20ac\u2122s vitro display technology, CIS display is used to discover biologically active peptides, proteins, and antibodies. Isogenica Limited was founded in 2000 and is based in Cambridge, the United Kingdom.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       85],
      "assets/images/resized/0006/0334/60334v1-max-150x150.jpg"],
     [[210,
       120],
      "assets/images/resized/0006/0334/60334v1-max-250x250.jpg"],
     [[210,
       120],
      "assets/images/resized/0006/0334/60334v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Kevin",
      "last_name": "Matthews",
      "permalink": "kevin-matthews",
      "image":
       {"available_sizes":
         [[[97,
            150],
           "assets/images/resized/0022/3305/223305v1-max-150x150.png"],
          [[145,
            223],
           "assets/images/resized/0022/3305/223305v1-max-250x250.png"],
          [[145,
            223],
           "assets/images/resized/0022/3305/223305v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "CSO",
    "person":
     {"first_name": "Chris",
      "last_name": "Ullman",
      "permalink": "chris-ullman",
      "image":
       {"available_sizes":
         [[[98,
            150],
           "assets/images/resized/0022/3306/223306v1-max-150x150.png"],
          [[145,
            221],
           "assets/images/resized/0022/3306/223306v1-max-250x250.png"],
          [[145,
            221],
           "assets/images/resized/0022/3306/223306v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "General Counsel",
    "person":
     {"first_name": "Anthony",
      "last_name": "M. Nixon",
      "permalink": "anthony-m-nixon",
      "image":
       {"available_sizes":
         [[[98,
            150],
           "assets/images/resized/0022/3307/223307v1-max-150x150.png"],
          [[145,
            221],
           "assets/images/resized/0022/3307/223307v1-max-250x250.png"],
          [[145,
            221],
           "assets/images/resized/0022/3307/223307v1-max-450x450.png"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://finance.yahoo.com/news/isogenica-secure-funding-uk-technology-090000504.html",
    "source_description": "Isogenica Secure Funding from UK\u2019s Technology Strategy Board to Develop Gene Library Synthesis Technology",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2012,
    "funded_month": 11,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Technology Strategy Board",
         "permalink": "technology-strategy-board",
         "image":
          {"available_sizes":
            [[[150,
               33],
              "assets/images/resized/0006/1550/61550v1-max-150x150.jpg"],
             [[250,
               55],
              "assets/images/resized/0006/1550/61550v1-max-250x250.jpg"],
             [[318,
               70],
              "assets/images/resized/0006/1550/61550v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "",
    "source_description": "",
    "acquired_year": 2008,
    "acquired_month": 5,
    "acquired_day": 6,
    "company":
     {"name": "Karyon-CTT",
      "permalink": "karyon-ctt",
      "image": null}}],
 "offices":
  [{"description": "",
    "address1": "Babraham Hall",
    "address2": "Babraham",
    "zip_code": "CB2 4AT",
    "city": "Cambridge",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}